Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Datamonitor
Datamonitor
Activities:
Media
Finance
X
LinkedIn
Trending Articles
Rentschler Biopharma appoints Patrick Cushing as VP Operations for US subsidiary
The novel position will require Dr Cushing to manager operations at the Miford, MA facility in the US
Making the most of each cell: single-use perfusion in biopharma processing
GEA kytero perfusion disk stack separators are pioneering the time- and cost-efficient harvesting of pharmaceutical proteins from cells and facilitating continuous processing,...
Johnson & Johnson submits regulatory application for Tremfya to the European Medicines Agency
The submission included data from the Phase 3 QUASAR programme in ulcerative colitis and the Phase 3 GALAXI programme in Crohn’s disease, which each achieved their primary...
Amolyt receives FDA fast track designation for hypoparathyroidism drug
The therapeutic has been awarded the fast track designation owing to the Phase III Calypso trial, which showed promising efficacy and safety features
Indian government bans three medicines owing to health risks
Decision follows strong stand on suspending marketing of all drugs prohibited for sale in other countries, including the US, UK, EU and Australia
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Media
Sales of generic HIV drugs to double by 2019
Patent expiries will halve existing HIV drug sales, says Datamonitor
Media
FDA approves therapy for prostate cancer
Manufactured by Seattle-based Dendreon
Media
US Health Bill a ‘double-edged sword’ for pharma sector
Mixed outlook for pharma industry but rising revenues expected from 2015 as volumes increase
Regulatory
Pulling back from the brink
The US healthcare reform bill raises as many questions as it answers for Big Pharma
Drug Delivery
Ondansetron RapidFilm gains European approval
Suitable for children and adults with swallowing difficulties
Media
Diabetes market to see rapid growth, says Datamonitor
But one of the main growth drivers of type 2 diabetes drugs will not be addressed on a large scale.
Media
Big Pharma CVD sales under threat from generics
Pharmaceutical companies will struggle to profit from the CVD market over the next 10 years.
Subscribe now